CATALOGO DEI PRODOTTI DELLA RICERCA

PESARINI, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.364
EU - Europa 5.136
AS - Asia 3.706
SA - Sud America 475
AF - Africa 148
Continente sconosciuto - Info sul continente non disponibili 116
OC - Oceania 12
Totale 14.957
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.211
RU - Federazione Russa 2.304
SG - Singapore 1.514
CN - Cina 1.019
GB - Regno Unito 898
IT - Italia 562
BR - Brasile 371
HK - Hong Kong 335
VN - Vietnam 316
FR - Francia 260
DE - Germania 252
SE - Svezia 228
IE - Irlanda 192
FI - Finlandia 185
KR - Corea 132
CA - Canada 77
IN - India 69
BD - Bangladesh 52
NL - Olanda 45
UA - Ucraina 42
ID - Indonesia 39
AR - Argentina 36
MX - Messico 36
ZA - Sudafrica 34
JP - Giappone 33
TR - Turchia 33
ES - Italia 30
TG - Togo 30
NG - Nigeria 29
IQ - Iraq 28
PL - Polonia 26
BE - Belgio 21
BJ - Benin 21
CO - Colombia 19
UZ - Uzbekistan 18
EC - Ecuador 15
PK - Pakistan 15
MA - Marocco 14
VE - Venezuela 14
LT - Lituania 13
AT - Austria 11
IR - Iran 11
AZ - Azerbaigian 10
JM - Giamaica 10
CZ - Repubblica Ceca 9
IL - Israele 9
KG - Kirghizistan 9
CH - Svizzera 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
AU - Australia 7
CL - Cile 7
OM - Oman 6
RO - Romania 6
TN - Tunisia 6
CR - Costa Rica 5
HU - Ungheria 5
NP - Nepal 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
BB - Barbados 4
BG - Bulgaria 4
DK - Danimarca 4
HN - Honduras 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
PS - Palestinian Territory 4
PT - Portogallo 4
TH - Thailandia 4
DO - Repubblica Dominicana 3
HR - Croazia 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TW - Taiwan 3
UY - Uruguay 3
BH - Bahrain 2
BO - Bolivia 2
BZ - Belize 2
EE - Estonia 2
EG - Egitto 2
GT - Guatemala 2
KH - Cambogia 2
LB - Libano 2
MT - Malta 2
PA - Panama 2
SI - Slovenia 2
TJ - Tagikistan 2
AO - Angola 1
BY - Bielorussia 1
CD - Congo 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
Totale 14.824
Salva come PNG Salva come JPEG
Città #
Moscow 814
Singapore 796
Ashburn 789
Southend 742
San Jose 655
Dallas 437
Chandler 368
Hong Kong 332
Jacksonville 226
Beijing 211
Council Bluffs 201
Verona 200
Dublin 190
New York 184
The Dalles 156
Los Angeles 126
Ho Chi Minh City 101
Munich 97
Helsinki 96
Woodbridge 96
Hanoi 85
Ann Arbor 82
Houston 76
Santa Clara 69
Jinan 65
Lawrence 58
Princeton 58
São Paulo 53
Wilmington 52
Shenyang 49
Buffalo 44
Milan 41
London 40
Tianjin 39
Nanjing 37
Redondo Beach 36
Hebei 34
Orem 34
Montreal 32
Turku 32
Denver 31
Seattle 31
Lomé 30
Seoul 29
Tokyo 29
Phoenix 28
Atlanta 27
Columbus 27
Frankfurt am Main 27
Rome 27
Sindelfingen 26
Abuja 24
Chennai 24
Johannesburg 24
Toronto 24
Amsterdam 23
Nanchang 23
Taizhou 23
Washington 23
Zhengzhou 23
Changsha 22
Brooklyn 21
Cedar Knolls 21
Cotonou 21
Guangzhou 21
Warsaw 21
Brussels 20
Haikou 20
Stockholm 20
Chicago 18
Taiyuan 18
Da Nang 17
McKinney 17
Ningbo 17
Kent 16
Poplar 16
Falkenstein 15
Haiphong 15
Hangzhou 15
Jakarta 15
San Francisco 15
Tashkent 15
Baghdad 14
Boston 14
Nuremberg 14
Paris 14
Redwood City 13
Brasília 12
Jiaxing 12
Lappeenranta 12
Mexico City 12
Rio de Janeiro 12
Belo Horizonte 11
Fairfield 11
Madrid 11
Norwalk 11
Biên Hòa 10
Fuzhou 10
Lanzhou 10
Shanghai 10
Totale 8.965
Salva come PNG Salva come JPEG
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 594
MODULAZIONE DELLA RISPOSTA INFIAMMATORIA NELLA PREVENZIONE DELLA RESTENOSI POST STENT CORONARICO: IL TRIAL CLINICO MULTICENTRICO RANDOMIZZATO “CEREA-DES” 230
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 225
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 214
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 211
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 203
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI 202
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 200
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 199
Hemodynamic predictors of long term survival in end stage cystic fibrosis 195
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 193
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 193
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 190
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 187
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 187
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 186
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 186
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 184
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 175
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 175
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 174
Impella-protected PCI: the clinical results achieved so far 171
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 170
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock 169
Acute electrocardiographic differences between Takotsubo cardiomyopathy and anterior ST elevation myocardial infarction 168
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 167
Coronary artery disease in patients undergoing transcatheter aortic valve implantation. A single centre registry on prevalence, management and immediate clinical impact 167
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 167
Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI 167
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis 166
Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcatheter Aortic Valve Implantation and Coronary Procedures 165
Intravascular ultrasound assessment of coronary ostia following valve in valve transcatheter aortic valve implantation 164
Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation 162
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 159
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 157
Angiography-derived index of microvascular resistance in takotsubo syndrome 156
Long-term variations of FFR and iFR after transcatheter aortic valve implantation 155
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI 154
Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy 154
Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation 154
Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy 153
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 152
New-onset extreme right axis deviation in acute myocardial infarction: clinical characteristics and outcomes 150
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 149
Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves 149
Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes 146
Risk stratification in acute coronary syndromes. 145
Comparison of the long-term survival benefits associated with revascularization or medical therapy in patients with known coronary artery disease undergoing transesophageal atrial pacing stress echocardiography 144
Bail-out transcatheter aortic valve implantation to reduce severe acute aortic regurgitation in a failing homograft secondary to HeartMate II ventricular assistance device 141
Early shifts in serum creatinine concentrations can predict contrast-induced nephropathy and persistent renal damage following angiography,Modificazioni precoci nella concentrazione della creatininemia sono in grado di predire la nefropatia da mezzo di contrasto e il danno renale persistente dopo angiografia 140
Extravalvular Cardiac Damage and Renal Function Following Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis 139
First Observation of a "Golden Tube" After Complete Resorption of a Bioresorbable Vascular Scaffold in a Transplanted Patient With Cardiac Allograft Vasculopathy 138
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions 138
Long-term intracoronary imaging and physiological measurements of bioresorbable scaffolds and untreated atherosclerotic plaques 137
Transapical mitral valve-in-valve procedure with elective venoarterial ECMO in a patient with severe kyphoscoliosis 137
Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES) 135
Vascular complications after transcatheter aortic valve implantation: treatment modalities and long-term clinical impact 130
Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy 130
Clinical Updates in Coronary Artery Disease: A Comprehensive Review 130
Radial artery occlusion after transradial procedures: impact on 1-year adverse events 130
Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses. 130
Recurrent very late drug-eluting stent thrombosis. 129
Choosing transcatheter aortic valve replacement in porcelain aorta: outcomes versus surgical replacement 127
Dynamic changes of repolarization abnormalities in takotsubo cardiomyopathy 126
Repeat revascularization: Percutaneous coronary intervention after coronary artery bypass graft surgery 125
Percutaneous Impella Recover circulatory support in high-risk coronary angioplasty. 119
Long-Term Outcomes of Coronary and Carotid Artery Disease Revascularization in the FRIENDS Study 119
Radial artery occlusion after conventional and distal radial access: Impact of preserved flow and time-to-hemostasis in a propensity-score matching analysis of 1163 patients 116
Transapical Transcatheter Aortic Valve Replacement: A Real-World Early and Mid-Term Outcome of a Third-Level Centre 114
Osteomyelitis of the clavicle following to a pacemaker implantation 114
Intraventricular entrapment of a Sapien-3 balloon in transapical TAVR: A near missed catastrophe 114
Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI 113
Quality of Life after Transcatheter Aortic Valve Replacement in Sarcopenic Patients Using the Toronto Aortic Stenosis Quality of Life Questionnaire 113
Right Ventricle Pulmonary Artery Coupling and Renal Function in Patients With Severe Aortic Stenosis Undergoing TAVR 112
Incomplete functional revascularization is associated with adverse clinical outcomes after transcatheter aortic valve implantation 111
Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction 111
Coronary obstruction after transcatheter aortic valve replacement combined with basilica procedure 110
Predictors of patent and occlusive hemostasis after transradial coronary procedures 110
Integrated Assessment of Computational Coronary Physiology From a Single Angiographic View in Patients Undergoing TAVI 108
Transcatheter tricuspid valve implantation by femoral approach in trivalvular heart disease 108
Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience 108
Early and late clinical outcomes of endovascular, surgical, and hybrid revascularization strategies of combined carotid and coronary artery diseases: the FRIENDS study group (Finalized Research In ENDovascular Strategies) 107
Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction 107
Ten-year experience with a transapical approach for transcatheter aortic and mitral valve implantation 105
Early Postoperative Thrombosis of Transcatheter Aortic Valve-in-Valve Prosthesis 104
Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry. 104
Single-side renal sympathetic denervation to treat malignant refractory hypertension in a solitary kidney patient 104
Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential. 104
Ten-Year Experience with Endomyocardial Biopsy after Orthotopic Heart Transplantation: Comparison between Trans-Jugular and Trans-Femoral Approach 102
Is transfemoral aortic valve implantation possible without contrast medium in patients with renal and multiorgan failure? 101
Current Antithrombotic Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions 98
Transfemoral Edwards-Novaflex valve implantation in a patient with aorto-iliac endoprosthesis and severely tortuous bilateral external iliac arteries-"Railing track" 95
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART) 95
Letter by Ribichini et al regarding article, "Cystatin C and contrast-induced acute kidney injury". 95
Increased Thrombogenicity is Associated With Coronary Microvascular Dysfunction in Patients With STEMI-A Proof-of-Concept Study 94
Short-and-Long-Term Outcomes after Coronary Rotational Atherectomy in Patients Treated with Trans-Catheter Aortic Valve Implantation 92
Transcatheter edge-to-edge mitral valve repair: what is the measure of success? 85
Significant Drop in Right Atrial Pressure Does Not Influence Fractional Flow Reserve Coronary Assessment 84
The promise of vascular reparative therapy in standby mode. How long before a final decision? Complete vessel wall regeneration and vascular scaffold resorption after left anterior descending reconstructions 79
The Influence of Aortic Valve Obstruction on the Hyperemic Intracoronary Physiology: Difference Between Resting Pd/Pa and FFR in Aortic Stenosis 79
Totale 14.679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.643
article - articoli 57.102
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 541
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022262 0 0 0 41 7 5 2 19 16 11 53 108
2022/20231.215 68 179 103 156 92 289 46 67 150 13 36 16
2023/20241.008 22 58 77 123 99 226 48 83 10 68 157 37
2024/20252.298 104 115 102 393 161 110 74 102 364 177 188 408
2025/20267.101 461 277 430 1.294 1.933 482 670 373 570 338 103 170
2026/2027897 81 200 188 428 0 0 0 0 0 0 0 0
Totale 14.957